newsfilter
← Latest News
GlobeNewswire·

Abeona Therapeutics® Announces First Patient Treatment with ZEVASKYN® Gene Therapy

CLEVELAND, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO) today announced the first commercial patient treatment with FDA-approved ZEVASKYN (prademagene zamikeracel), a first-of-its-kind,